Xiaojuan Zhai - Biostar Pharmaceuticals Chief Officer
| BSPMDelisted Stock | USD 0.01 0.00 0.00% |
Executive
Ms. Xiaojuan Zhai serves as Chief Financial Officer of the Company. Prior to this appointment, from September 2015 to February 2017, Ms. Zhai served as a Deputy CFO at Shaanxi Aoxing Pharmaceutical Co., Ltd., the Companys PRC affiliate. Prior to that appointment, she was employed as an Accounting Supervisor at Dahua Biological Technology Investment Co., Ltd. Ms. Zhai holds a degree in Accounting from Xian Peihua University. since 2017.
| Age | 34 |
| Tenure | 7 years |
| Phone | 86 29 3368 6638 |
| Web | https://biostarpharmaceuticals.com |
Biostar Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of 0.0425 % which means that it generated a profit of $0.0425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0266 %, meaning that it created $0.0266 on every $100 dollars invested by stockholders. Biostar Pharmaceuticals' management efficiency ratios could be used to measure how well Biostar Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Greg Martini | Ironwood Pharmaceuticals | N/A | |
| John Hamm | Cumberland Pharmaceuticals | 68 | |
| Marcel Moulaison | Ironwood Pharmaceuticals | N/A | |
| Kara Morley | Lifecore Biomedical | N/A | |
| Chaime Orlev | Kamada | 54 | |
| Michael MD | Ironwood Pharmaceuticals | 65 | |
| Timothy CPA | Shuttle Pharmaceuticals | 66 | |
| Todd Anthony | Cumberland Pharmaceuticals | 63 | |
| Jean Marstiller | Cumberland Pharmaceuticals | 74 | |
| Shavit Beladev | Kamada | N/A | |
| Erin Gull | Cumberland Pharmaceuticals | N/A | |
| Chris Bitterman | Cumberland Pharmaceuticals | 59 | |
| Ronald Silver | Ironwood Pharmaceuticals | 41 | |
| Jon Knight | Kamada | 58 | |
| Amir London | Kamada | 55 | |
| Darren Hieber | Lifecore Biomedical | N/A | |
| Liron Reshef | Kamada | 53 | |
| Hanni Neheman | Kamada | 54 | |
| Brikkelle Thompson | Lifecore Biomedical | N/A | |
| Boris Gorelik | Kamada | 43 | |
| Jackie Klecker | Lifecore Biomedical | N/A | |
Management Performance
| Return On Equity | 0.0266 | ||||
| Return On Asset | 0.0425 |
Biostar Pharmaceuticals Leadership Team
Elected by the shareholders, the Biostar Pharmaceuticals' board of directors comprises two types of representatives: Biostar Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biostar. The board's role is to monitor Biostar Pharmaceuticals' management team and ensure that shareholders' interests are well served. Biostar Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biostar Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Zhenghong Wang, Chief Officer | ||
| Pr Zheng, Chief Scientist | ||
| Ronghua Wang, Chairman, CEO and President Chairman of Aoxing Pharmaceutical Inc, CEO of Aoxing Pharmaceutical Inc and President of Aoxing Pharmaceutical Inc | ||
| Xiaojuan Zhai, Chief Officer | ||
| Shuang Gong, Secretary of Board |
Biostar Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Biostar Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0266 | ||||
| Return On Asset | 0.0425 | ||||
| Profit Margin | 2.94 % | ||||
| Operating Margin | 8.76 % | ||||
| Current Valuation | 316.46 K | ||||
| Shares Outstanding | 2.64 M | ||||
| Number Of Shares Shorted | 170.44 K | ||||
| Price To Book | 0.01 X | ||||
| Price To Sales | 0.0001 X | ||||
| Revenue | 317.79 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Biostar Pink Sheet
If you are still planning to invest in Biostar Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biostar Pharmaceuticals' history and understand the potential risks before investing.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |